1. Combining immunoscore and tumor budding in colon cancer: an insightful prognostication based on the tumor-host interface
- Author
-
T. S. Haddad, J. M. Bokhorst, M. D. Berger, L. v. d. Dobbelsteen, F. Simmer, F. Ciompi, J. Galon, J. v. d. Laak, F. Pagès, I. Zlobec, A. Lugli, and I. D. Nagtegaal
- Subjects
Immunoscore ,Tumor budding ,Colon cancer ,AI ,Medicine - Abstract
Abstract Background Tumor Budding (TB) and Immunoscore are independent prognostic markers in colon cancer (CC). Given their respective representation of tumor aggressiveness and immune response, we examined their combination in association with patient disease-free survival (DFS) in pTNM stage I-III CC. Methods In a series of pTNM stage I-III CCs (n = 654), the Immunoscore was computed and TB detected automatically using a deep learning network. Two-tiered systems for both biomarkers were used with cut-offs of 25% and ten buds for Immunoscore and TB according to clinical guidelines, respectively. Associations of Immunoscore with TB with 5-year DFS were examined using Kaplan–Meier survival analysis in addition to multivariable modeling and relative contribution analysis using Cox regression. Results Immunoscore and TB independently are prognostic with hazard ratio (HR) = 2.0, 95% confidence interval (CI) 1.4–2.8 and HR 2.5, with 95% CI 1.4–4.5, respectively; P value
- Published
- 2024
- Full Text
- View/download PDF